SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| View HTML | Additional proxy soliciting materials - definitive |
DEFA14A |
Proxy Filings
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | Annual report which provides a comprehensive overview of the company for the past year |
10-K |
Annual Filings
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to the SC 13G filing |
SC 13G/A |
Other
|
Eidos Therapeutics, Inc. |
Displaying 11 - 20 of 146 results
Data provided by Kaleidoscope.